Inspire Medical Systems (NYSE:INSP – Get Free Report) and Microbot Medical (NASDAQ:MBOT – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.
Profitability
This table compares Inspire Medical Systems and Microbot Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Inspire Medical Systems | 4.37% | 5.30% | 4.58% |
| Microbot Medical | N/A | -218.30% | -158.17% |
Institutional and Insider Ownership
94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 16.3% of Microbot Medical shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 10.5% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Inspire Medical Systems | $755.59 million | 7.88 | -$21.15 million | $1.07 | 185.68 |
| Microbot Medical | N/A | N/A | -$10.74 million | ($0.80) | -2.68 |
Microbot Medical has lower revenue, but higher earnings than Inspire Medical Systems. Microbot Medical is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a breakdown of current ratings for Inspire Medical Systems and Microbot Medical, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Inspire Medical Systems | 0 | 3 | 9 | 0 | 2.75 |
| Microbot Medical | 0 | 0 | 1 | 0 | 3.00 |
Inspire Medical Systems presently has a consensus price target of $233.58, suggesting a potential upside of 17.57%. Microbot Medical has a consensus price target of $7.00, suggesting a potential upside of 227.10%. Given Microbot Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Microbot Medical is more favorable than Inspire Medical Systems.
Risk and Volatility
Inspire Medical Systems has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Microbot Medical has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500.
Summary
Inspire Medical Systems beats Microbot Medical on 8 of the 13 factors compared between the two stocks.
About Inspire Medical Systems
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
About Microbot Medical
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
